The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women

Completed · Not applicable

Conditions studied: Infertility, Female

In brief

Dr. Roseff and his colleagues are conducting a study to evaluate the effectiveness of a novel substance (Inofolic Plus®) in improving oocyte (egg) parameters in subfertile female patients, as measured through Anti-Mullerian Hormone (AMH) blood levels.

Key facts

Study ID

NCT01290432

Run by

Palm Beach Center for Reproductive Medicine

People needed

15

Starts

2011-02-01

Expected to finish

2012-02-01

Last updated by the study team

2012-05-25

Who can join

Age: 18 and older, up to 42. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female between 18 - 42 years of age
• Diagnosed with "Diminished Ovarian Reserve" (DOR)

You may not qualify if…

• Ongoing history of illicit drug or tobacco use
• Ovarian surgery within 90 days of signing the consent form

Where it is running

• Palm Beach Center for Reproductive Medicine — Wellington, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.